This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Honeywell (HON) to Buy US Digital Designs, To Aid Public Safety
by Zacks Equity Research
Honeywell's (HON) US Digital Designs acquisition is expected to boost its offerings for improving public safety communications. US Digital Designs will be part of the Building Technologies segment.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $319.28, moving +0.32% from the previous trading session.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $312.94, marking a -0.99% move from the previous day.
The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Chevron, Medtronic and Danaher
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Chevron, Medtronic and Danaher
Top Stock Reports for Microsoft, JPMorgan Chase & Chevron
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), JPMorgan Chase & Co. (JPM) and Chevron Corporation (CVX).
Danaher (DHR) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Zacks Industry Outlook Highlights: Danaher, Carlisle Companies, Raven Industries and Griffon Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Danaher, Carlisle Companies, Raven Industries and Griffon Corp
4 Must-Watch Stocks in Gloomy Diversified Operations Industry
by Payal Jalan
Supply-chain, logistics and labor woes are limiting growth in the Zacks Diversified Operations industry. Despite this, DHR, CSL, RAVN and GFF are showing strength and must be on investors' watch list.
General Electric (GE) Tops Q3 Earnings Estimates, Ups '21 View
by Zacks Equity Research
General Electric's (GE) Q3 earnings reflect the impacts of strength in Aviation, and weak Healthcare and Renewable Energy. It lowers 2021 Industrial organic revenue view and ups the same for earnings.
3M (MMM) Q3 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
3M's (MMM) third-quarter 2021 revenues increase 7.1% year over year on account of impressive performance across its segments.
Danaher (DHR) Beats on Q3 Earnings, Ups 2021 Core Sales View
by Zacks Equity Research
Danaher's (DHR) Q3 results reflect healthy demand for products in its three segments and a better gross margin. Pandemic-induced demand too adds to sales growth. It raises the core sales view for 2021.
Honeywell (HON) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Honeywell's (HON) third-quarter 2021 revenues increase 9% year over year on account of impressive performance across all of its segments.
Carlisle (CSL) Q3 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) third-quarter 2021 revenues increase 24.5% year over year on account of impressive performance across its segments.
Looking for a Growth Stock? 3 Reasons Why Danaher (DHR) is a Solid Choice
by Zacks Equity Research
Danaher (DHR) possesses solid growth attributes, which could help it handily outperform the market.
Danaher (DHR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 11.68% and 3.09%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Optimism Reenters The Market But Will It Last As Earnings Season Picks Up?
by Daniel Laboe
All the major averages have officially broken above their 50-day moving averages, a pivotal "risk-on" technical signal as we enter the heart of Q3 earnings season
Danaher (DHR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEF
Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DEF
Solid U.S. Economic Fundamentals to Drive Wall Street in Q4
by Nalak Das
We have narrowed down our search to some U.S. corporate behemoths with attractive valuation. These are: CRM, MSFT, WMT, DE, TSLA, DHR, SQ and COST.
Bull of the Day: Mesa Laboratories (MLAB)
by Kevin Cook
Key M&A boosts sales & EPS, opens path to new business with Clinical Genomics Division
Why Danaher (DHR) Could Beat Earnings Estimates Again
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.